Lab
Leannah Investment Partners, LTD
Leannah Investment Partners, LTD was paid $264K by Medicaid between Jan 2018 and Aug 2022, across 99 billing codes. Its largest line is 80050, General health panel — 10.0% of everything it billed.
33Billing provider infoLEANNAH INVESTMENT PARTNERS, LTD
FRISCO, TX 75035
FRISCO, TX 75035
33aNPI1649354085assigned 10/24/2006
33bProvider typeClinical Medical Laboratory
28Total paid$264K
24GClaims86,369
24DCodes billed99
24AFirst – last monthJan 2018 – Aug 2022
Compared with peers
Next to other Clinical Medical Laboratory providers in Texas
Rank by total paid#117 of 436
Median peer was paid$17K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 59,413 | $170K | |
| 2019 | 23,760 | $92K | |
| 2020 | 756 | $258.16 | |
| 2021 | 1,670 | $1K | |
| 2022 | 770 | $372.96 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80050 | General health panel | 10.0% | 630 | 626 | $26K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6.3% | 1,534 | 1,461 | $17K |
| 84403 | 5.0% | 927 | 911 | $13K | |
| 82670 | 4.6% | 826 | 812 | $12K | |
| 84270 | 4.2% | 909 | 888 | $11K | |
| 83001 | 3.6% | 890 | 881 | $9K | |
| 83002 | 3.6% | 887 | 879 | $9K | |
| 80061 | Lipid panel | 3.6% | 3,128 | 2,983 | $9K |
| 82533 | 3.1% | 927 | 910 | $8K | |
| 82728 | 3.0% | 1,106 | 1,079 | $8K | |
| 82607 | 3.0% | 1,276 | 1,230 | $8K | |
| 82746 | 3.0% | 1,253 | 1,217 | $8K |
87 more codes
| 83880 | 3.0% | 829 | $8K | |
| 84481 | 2.9% | 921 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.7% | 3,846 | $7K |
| 84466 | 2.7% | 1,031 | $7K | |
| 86376 | 2.6% | 754 | $7K | |
| 84134 | 2.4% | 852 | $6K | |
| 86141 | 2.4% | 976 | $6K | |
| 86800 | 2.4% | 653 | $6K | |
| 83525 | 2.1% | 892 | $6K | |
| 82627 | 2.1% | 630 | $6K | |
| 84146 | 2.0% | 671 | $5K | |
| 84144 | 1.9% | 502 | $5K | |
| 83540 | 1.4% | 1,083 | $4K | |
| 84439 | 1.2% | 1,114 | $3K | |
| 84402 | 1.0% | 146 | $3K | |
| 84550 | <1% | 1,217 | $2K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 294 | $2K |
| 83690 | <1% | 786 | $2K | |
| 83498 | <1% | 142 | $2K | |
| 82150 | <1% | 794 | $2K | |
| 84153 | <1% | 235 | $2K | |
| 82172 | <1% | 411 | $2K | |
| 84432 | <1% | 289 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 6,712 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 553 | $1K |
| 84436 | <1% | 922 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,807 | $1K |
| 83550 | <1% | 398 | $1K | |
| 84479 | <1% | 521 | $1K | |
| 82610 | <1% | 379 | $1K | |
| 83090 | <1% | 451 | $937.86 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,943 | $876.65 |
| 82248 | <1% | 646 | $823.10 | |
| 84480 | <1% | 464 | $784.96 | |
| 83970 | <1% | 139 | $747.48 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 255 | $630.40 |
| 83735 | <1% | 781 | $523.35 | |
| 84702 | <1% | 165 | $512.69 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $463.32 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $463.32 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 13 | $463.32 |
| 86431 | <1% | 417 | $449.03 | |
| 82105 | <1% | 328 | $445.00 | |
| 83615 | <1% | 505 | $438.26 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 12 | $427.68 |
| 85652 | <1% | 286 | $418.50 | |
| 85045 | <1% | 281 | $395.56 | |
| 82784 | <1% | 248 | $389.50 | |
| 84100 | <1% | 564 | $337.75 | |
| 82977 | <1% | 454 | $332.98 | |
| 80164 | <1% | 604 | $199.79 | |
| 80185 | <1% | 390 | $196.98 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,772 | $179.49 |
| 82550 | <1% | 157 | $114.88 | |
| 87186 | <1% | 919 | $45.91 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,341 | $38.96 |
| 87088 | <1% | 881 | $34.58 | |
| 81001 | <1% | 1,866 | $28.12 | |
| 80156 | <1% | 155 | $16.78 | |
| 84446 | <1% | 32 | $14.71 | |
| 80184 | <1% | 13 | $13.20 | |
| 82947 | <1% | 126 | $12.77 | |
| 81000 | <1% | 336 | $10.95 | |
| 80076 | <1% | 105 | $9.42 | |
| 85610 | 0% | 1,706 | $0.00 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 1,022 | $0.00 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 94 | $0.00 |
| 82570 | 0% | 164 | $0.00 | |
| 83695 | 0% | 18 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 12 | $0.00 |
| 80162 | 0% | 97 | $0.00 | |
| 82565 | 0% | 18 | $0.00 | |
| 84520 | 0% | 16 | $0.00 | |
| 82247 | 0% | 12 | $0.00 | |
| 87070 | 0% | 69 | $0.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 102 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 10,435 | $0.00 |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 0% | 3,475 | $0.00 |
| 82040 | 0% | 13 | $0.00 | |
| 86430 | 0% | 25 | $0.00 | |
| 80069 | 0% | 35 | $0.00 | |
| 84132 | 0% | 13 | $0.00 | |
| 80177 | 0% | 103 | $0.00 | |
| 85651 | 0% | 45 | $0.00 | |
| 82043 | 0% | 142 | $0.00 | |
| 86140 | 0% | 395 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRAY, KEITH (AUTHORIZED OFFICAL)
| Provider | Location | Paid |
|---|---|---|
| Axis Professional Labs LLC | Farmers Branch, TX | $459K |
| Beta Biosciences, LLC | Kansas City, MO | $55K |
| Kingdom Health Laboratory LLC | Dallas, TX | $19K |
| Global Reach Labs, LLC | Denver, CO | $408.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.